CIMETIDINE IN DUODENAL ULCER Controlled Trial
Authors:
- W.S. BlackwoodWBW.S. Blackwood
- R.G. PickardRPR.G. Pickard
- D.P. MaudgalDMD.P. Maudgal
- D. LawrenceDLD. Lawrence
- T.C. NorthfieldTNT.C. Northfield
- 1 July 1976
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 308 (7978) , 174-176
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- TREATMENT OF DUODENAL ULCER WITH CIMETIDINEThe Lancet, 1976
- Pharmacological evaluation of cimetidine, a new histamine H2‐receptor antagonist, in healthy man.British Journal of Clinical Pharmacology, 1975
- REVERSAL OF METIAMIDE-INDUCED AGRANULOCYTOSIS DURING TREATMENT WITH CIMETIDINEThe Lancet, 1975
- Relief of duodenal ulcer sysmptons by oral metiamide.BMJ, 1975
- The effect of an H2-receptor antagonist on food-stimjlated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcers. Comparison with an anticholinergic drug.Journal of Clinical Investigation, 1975
- Cimetidine—A Non-Thiourea H2-Receptor AntagonistJournal of International Medical Research, 1975
- Effect of Histamine H 2 -Receptor Blockade on Vagally Induced Gastric Secretion in ManBMJ, 1974
- Metiamide, an H2-Receptor Blocker, as Inhibitor of Basal and Meal-Stimulated Gastric Acid Secretion in Patients with Duodenal UlcerNew England Journal of Medicine, 1974
- EFFECTS IN MAN OF HISTAMINE H2-RECEPTOR BLOCKADE BY BURIMAMIDEThe Lancet, 1972
- Definition and Antagonism of Histamine H2-receptorsNature, 1972